Corolla Pharmaceutical Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 19-12-2024
- Paid Up Capital ₹ 99.00 K
as on 19-12-2024
- Company Age 7 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 0.51 M
as on 19-12-2024
- Revenue 346.93%
(FY 2020)
- Profit 22.87%
(FY 2020)
- Ebitda -767.78%
(FY 2020)
- Net Worth -17.75%
(FY 2020)
- Total Assets 33.68%
(FY 2020)
About Corolla Pharmaceutical
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 99.00 K .
The company currently has active open charges totaling ₹0.51 M.
Mamta Gupta and Nidhi Agarwal serve as directors at the Company.
- CIN/LLPIN
U74999TN2017PTC118141
- Company No.
118141
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Aug 2017
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Corolla Pharmaceutical?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mamta Gupta  | Director | 16-Aug-2017 | Current |
| Nidhi Agarwal | Director | 10-Feb-2023 | Current |
Financial Performance of Corolla Pharmaceutical.
Corolla Pharmaceutical Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 346.93% increase. The company also saw a substantial improvement in profitability, with a 22.87% increase in profit. The company's net worth observed a substantial decline by a decrease of 17.75%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Corolla Pharmaceutical?
Unlock access to Corolla Pharmaceutical's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 21 Jun 2023 | ₹0.51 M | Open |
How Many Employees Work at Corolla Pharmaceutical?
Unlock and access historical data on people associated with Corolla Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Corolla Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Corolla Pharmaceutical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
